c-Rel antibody (AA 116-610) (HRP)
Quick Overview for c-Rel antibody (AA 116-610) (HRP) (ABIN8031316)
Target
See all c-Rel AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 116-610
-
Purpose
- Anti-c-Rel/REL Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human c-Rel/REL recombinant protein (Position: K116-D610).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- c-Rel (REL proto-oncogene (c-Rel))
-
Alternative Name
- REL
-
Background
-
Background: The proto-oncogene c-Rel is a protein that in humans is encoded by the REL gene This gene encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of this gene is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in this gene are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms.
Gene Full Name: REL proto-oncogene, NF-kB subunit
-
Gene ID
- 5966
-
UniProt
- Q04864
Target
-